Jianye Wu

2.8k total citations · 2 hit papers
43 papers, 2.1k citations indexed

About

Jianye Wu is a scholar working on Molecular Biology, Epidemiology and Cancer Research. According to data from OpenAlex, Jianye Wu has authored 43 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 15 papers in Epidemiology and 11 papers in Cancer Research. Recurrent topics in Jianye Wu's work include Liver Disease Diagnosis and Treatment (13 papers), Peroxisome Proliferator-Activated Receptors (8 papers) and Cancer, Hypoxia, and Metabolism (5 papers). Jianye Wu is often cited by papers focused on Liver Disease Diagnosis and Treatment (13 papers), Peroxisome Proliferator-Activated Receptors (8 papers) and Cancer, Hypoxia, and Metabolism (5 papers). Jianye Wu collaborates with scholars based in China, India and Germany. Jianye Wu's co-authors include Chuanyong Guo, Jingjing Li, Liwei Wu, Qiang Yu, Jiao Feng, Weiqi Dai, Jie Ji, Yuqing Mao, Jie Zhang and Kan Chen and has published in prestigious journals such as Free Radical Biology and Medicine, British Journal of Pharmacology and World Journal of Gastroenterology.

In The Last Decade

Jianye Wu

42 papers receiving 2.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Emerging roles and the regulation of aerobic glycolysis in hepatocellular carcinoma

2020 474 citations Jiao Feng, Jingjing Li et al. Journal of Experimental & Clinical Cancer Research profile →
Targeting fatty acid synthase modulates sensitivity of hepatocellular carcinoma to sorafenib via ferroptosis

2023 107 citations Yan Li, Wenjuan Yang et al. Journal of Experimental & Clinical Cancer Research profile →

Peers

Jianye Wu

EPIDE

PRM

ONCOL

Qiang Yu China

Taotao Ma China

Desong Kong China

Na Han China

Xufeng Tao China

Zhi Dai China

Yujing Xia China

Ming Niu China

Yuqing Mao China

Shi-Bing Su China

Qiang Yu China

Jianye Wu

1.3k ×1.1

778 ×1.1

630 ×1.3

EPIDE

204 ×0.8

PRM

302 ×1.2

ONCOL

Citations per year, relative to Jianye Wu Jianye Wu (= 1×) peers Qiang Yu

Countries citing papers authored by Jianye Wu

Since Specialization

Citations

This map shows the geographic impact of Jianye Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jianye Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jianye Wu more than expected).

Fields of papers citing papers by Jianye Wu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jianye Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jianye Wu. The network helps show where Jianye Wu may publish in the future.

Co-authorship network of co-authors of Jianye Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Jianye Wu. A scholar is included among the top collaborators of Jianye Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jianye Wu. Jianye Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhou, Xinwen, et al.. (2025). Nucleotide-Bound Oligomeric Domain-Like Receptor Protein 3 as a Serological Biomarker in Relation to Disease Severity and Delirium After Acute Pancreatitis: A Two-Center Prospective Cohort Study. International Journal of General Medicine. Volume 18. 3423–3440.

Zhang, Jie, Ziqi Cheng, Jie Ji, et al.. (2024). TRIM47-CDO1 axis dictates hepatocellular carcinoma progression by modulating ferroptotic cell death through the ubiquitin‒proteasome system. Free Radical Biology and Medicine. 219. 31–48. 6 indexed citations

Zheng, Yuanyuan, Wenjuan Yang, Yewei Jia, et al.. (2023). Promotion of colorectal cancer cell death by ezetimibe via mTOR signaling-dependent mitochondrial dysfunction. Frontiers in Pharmacology. 14. 1081980–1081980. 4 indexed citations

Li, Yan, Wenjuan Yang, Yuanyuan Zheng, et al.. (2023). Targeting fatty acid synthase modulates sensitivity of hepatocellular carcinoma to sorafenib via ferroptosis. Journal of Experimental & Clinical Cancer Research. 42(1). 6–6. 107 indexed citations breakdown →

Zhang, Jie, et al.. (2023). Deciphering roles of TRIMs as promising targets in hepatocellular carcinoma: current advances and future directions. Biomedicine & Pharmacotherapy. 167. 115538–115538. 9 indexed citations

Cheng, Ping, Weiqi Dai, Jie Ji, et al.. (2021). Fenofibrate Ameliorates Hepatic Ischemia/Reperfusion Injury in Mice: Involvements of Apoptosis, Autophagy, and PPAR-α Activation. PPAR Research. 2021. 1–16. 14 indexed citations

Wu, Liwei, Jingjing Li, Jiao Feng, et al.. (2021). Crosstalk between PPARs and gut microbiota in NAFLD. Biomedicine & Pharmacotherapy. 136. 111255–111255. 42 indexed citations

Li, Yan, Yuanyuan Zheng, Liwei Wu, et al.. (2021). Current status of ctDNA in precision oncology for hepatocellular carcinoma. Journal of Experimental & Clinical Cancer Research. 40(1). 140–140. 26 indexed citations

Xu, Shizan, Yuqing Mao, Jianye Wu, et al.. (2020). TGF‐β/Smad and JAK/STAT pathways are involved in the anti‐fibrotic effects of propylene glycol alginate sodium sulphate on hepatic fibrosis. Journal of Cellular and Molecular Medicine. 24(9). 5224–5237. 42 indexed citations

10.

Liu, Tong, Sainan Li, Liwei Wu, et al.. (2020). Experimental Study of Hepatocellular Carcinoma Treatment by Shikonin Through Regulating PKM2. Journal of Hepatocellular Carcinoma. Volume 7. 19–31. 49 indexed citations

11.

Yu, Qiang, Liwei Wu, Jie Ji, et al.. (2020). Gut Microbiota, Peroxisome Proliferator-Activated Receptors, and Hepatocellular Carcinoma. Journal of Hepatocellular Carcinoma. Volume 7. 271–288. 19 indexed citations

12.

Wu, Liwei, Chuanyong Guo, & Jianye Wu. (2020). Therapeutic potential of PPARγ natural agonists in liver diseases. Journal of Cellular and Molecular Medicine. 24(5). 2736–2748. 89 indexed citations

13.

Feng, Jiao, Weiqi Dai, Yuqing Mao, et al.. (2020). Simvastatin re-sensitizes hepatocellular carcinoma cells to sorafenib by inhibiting HIF-1α/PPAR-γ/PKM2-mediated glycolysis. Journal of Experimental & Clinical Cancer Research. 39(1). 24–24. 169 indexed citations

14.

Ji, Jie, Liwei Wu, Jiao Feng, et al.. (2020). Cafestol preconditioning attenuates apoptosis and autophagy during hepatic ischemia-reperfusion injury by inhibiting ERK/PPARγ pathway. International Immunopharmacology. 84. 106529–106529. 26 indexed citations

15.

Li, Jingjing, Chuanyong Guo, & Jianye Wu. (2020). Astaxanthin in Liver Health and Disease: A Potential Therapeutic Agent. Drug Design Development and Therapy. Volume 14. 2275–2285. 63 indexed citations

16.

Feng, Jiao, Jingjing Li, Liwei Wu, et al.. (2020). Emerging roles and the regulation of aerobic glycolysis in hepatocellular carcinoma. Journal of Experimental & Clinical Cancer Research. 39(1). 126–126. 474 indexed citations breakdown →

17.

Wang, Wenwen, Liwei Wu, Jingjing Li, et al.. (2019). Alleviation of Hepatic Ischemia Reperfusion Injury by Oleanolic Acid Pretreating via Reducing HMGB1 Release and Inhibiting Apoptosis and Autophagy. Mediators of Inflammation. 2019. 1–10. 39 indexed citations

18.

Li, Jingjing, Chuanyong Guo, & Jianye Wu. (2019). 15-Deoxy-∆-^12,14-Prostaglandin J2 (15d-PGJ2), an Endogenous Ligand of PPAR-γ: Function and Mechanism. PPAR Research. 2019. 1–10. 74 indexed citations

19.

Wu, Jianye, Xuanfu Xu, Ling Xu, et al.. (2011). Cyclopamine Blocked the Growth of Colorectal Cancer SW116 Cells by Modulating Some Target Genes of Gli1 in vitro. Hepatogastroenterology. 58(110-111). 1511–8. 19 indexed citations

20.

Guo, Chuanyong, Xuanfu Xu, Jianye Wu, & Shufang Liu. (2008). PCR-SSCP-DNA sequencing method in detecting PTEN gene mutation and its significance in human gastric cancer. World Journal of Gastroenterology. 14(24). 3804–3804. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact